To us, at Cipla, people, planet and purpose will always remain fundamental to our existence. We are humbled to be a part of an industry that works to make a difference to the society, to mankind. For all of us at Cipla, our humanitarian purpose continues to guide us with a single-minded goal to care for life.
We believe in living our purpose of ‘Caring of Life’ for people, nature and the planet. We are committed to using a science-based approach to innovate, create sustainable value and to solve the climate change challenge faced by the world today. We consistently strive to ensure responsible management of our environmental footprint and conservation of natural capital around us.
This year, we set for ourselves bold aspirations in our sustainability journey and here, we reflect upon it.Download Annual Report
At Cipla, our people are our biggest assets- they are the constant enablers of the Company’s purpose of 'Caring for Life'. Our workforce of over 25000 employees across the world are the pillars of our strength. Their unwavering commitment and dedication to Cipla and towards our purpose and vision, enables us to serve millions of patients around the world.
During the year, our people demonstrated unparalleled passion and commitment in combating the challenges imposed by Covid-19.
In FY 2020-21, Cipla contributed significantly to the global efforts in combating COVID-19 and delivered on its promise of ‘Caring for Life’. We supported the Government and frontline workers across geographies and offered our comprehensive product portfolio for diagnosis and treatment under partnerships.
The untiring efforts of our manufacturing and R&D colleagues at the sites, to the steadfast commitment of the sales teams, to the resilience of the supply chain, operations and admin teams ensured that together Cipla did everything to supply medicines to patients, while being at the forefront of this fight against the global pandemic.
Care is at the core of everything we do at Cipla. With over two billion people estimated to lack regular access to essential medicines, healthcare access cannot currently be described as equitable. Recognising that only a small number of patients in some low and middle-income countries can afford medicines, Cipla works to improve access, availability and affordability for life-saving medicines.
Being amongst the most prevalent brands in respiratory therapies, we build strong bonds with our patients to deepen our understanding of individual and market needs and be able to cater to the requirements of this key stakeholder segment. Through various campaigns and digital programs, we intend to educate our patients about respiratory problems and enable them understand the respiratory conditions and be able to use their inhaler devices better.
At Cipla, we believe in living by our ethos of contributing towards a greener environment and sustainable value creation. We do recognize the impact of our business activities on the environment and consistently strive to ensure responsible environment management and conservation to encourage sustainable profits for people and the planet.
Our Sustainability Goals 2025 are aligned to the operating context of our sector and its impact on various capitals.